HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 2,629-2,640 of 4,505
Drug study icon
CompletedNCT03669250

CVN058 Effect on Mismatch Negativity in Schizophrenics

Official study title

A Placebo-Controlled Study to Evaluate the Effect of a Single Dose of CVN058 on Mismatch Negativity in Subjects With Stable Schizophrenia

This study has finished and is no longer accepting participants.

In New York
SchizophreniaMedication studyAges 18–50
Countries
United States
Sponsor
Cerevance Alpha, Inc.
Drug study icon
CompletedNCT02156908

D-serine and Cognitive Remediation in Schizophrenia

Official study title

D-serine and Cognitive Remediation in Schizophrenia: Open Label Pilot

This study has finished and is no longer accepting participants.

In Orangeburg
SchizophreniaMedication studyAges 18–64
Countries
United States
Sponsor
Nathan Kline Institute for Psychiatric Research
Drug study icon
SuspendedNCT05046353

D-serine AudRem: R33 Phase

Official study title

D-serine Augmentation of Neuroplasticity-based Auditory Learning in Schizophrenia: R33 Phase

Recruitment is currently suspended.

In New York
SchizophreniaMedication studyAges 18–50
Countries
United States
Sponsor
New York State Psychiatric Institute
Drug study icon
CompletedNCT03711500

D-serine Augmentation of Neuroplasticity

Official study title

D-serine Augmentation of Neuroplasticity Based Auditory Learning in Schizophrenia

This study has finished and is no longer accepting participants.

Multiple locations, including New York
SchizophreniaMedication studyAges 18–50
Countries
United States
Sponsor
New York State Psychiatric Institute
Drug study icon
TerminatedNCT01712646

Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia

Official study title

The Use of Daily, Intranasal Oxytocin for the Treatment of Childhood-Onset Schizophrenia (COS), a Randomized Double-Blind Trial

This study ended early.

In Bethesda
SchizophreniaMedication studyAges 10–99
Countries
United States
Sponsor
National Institute of Mental Health (NIMH) (Government agency)
Other study type icon
CompletedNCT02187835

Decreased EEG Complexity in Schizophrenia

Official study title

Decreased EEG Complexity in Chronic Residual Schizophrenia

This study has finished and is no longer accepting participants.

In Istanbul
SchizophreniaObservational studyAges 18–65
Countries
Türkiye
Sponsor
Uskudar University

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.